Literature DB >> 10073523

Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment.

R L Green, A G Vayonis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10073523     DOI： 10.1016/S0140-6736(99)00565-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

Review 1.  Churg-Strauss syndrome.

Authors:  M Conron; H L Beynon
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 2.  Antileukotriene drugs in childhood asthma: what is their place in therapy?

Authors:  H Selvadurai; C Mellis
Journal:  Paediatr Drugs       Date:  2000 Sep-Oct       Impact factor: 3.022

Review 3.  Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma.

Authors:  C J Dunn; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  Churg-Strauss syndrome and the leukotriene receptor antagonist pranlukast.

Authors:  Junsuke Shimbo; Osamu Onodera; Keiko Tanaka; Shoji Tsuji
Journal:  Clin Rheumatol       Date:  2004-12-02       Impact factor: 2.980

Review 5.  Pharmacokinetic profile of zafirlukast.

Authors:  P N Richard Dekhuijzen; Peter P Koopmans
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 6.  Montelukast: a review of its therapeutic potential in persistent asthma.

Authors:  B Jarvis; A Markham
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

7.  Fulminant eosinophilic endomyocarditis in an asthmatic patient treated with pranlukast after corticosteroid withdrawal.

Authors:  S Hayashi; S Furuya; H Imamura
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

8.  Churg-Strauss syndrome with severe granulomatous angiitis and crescentic glomerulonephritis, which developed during therapy with a leukotriene receptor antagonist.

Authors:  Takahiro Kanda; Hitoshi Tanio; Chunmo Wu; Hiroji Nishihara; Fumiaki Nogaki; Takahiko Ono
Journal:  Clin Exp Nephrol       Date:  2010-07-06       Impact factor: 2.801

Review 9.  Benefit-risk assessment of antileukotrienes in the management of asthma.

Authors:  Luis García-Marcos; Antje Schuster; Eduardo G Pérez-Yarza
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

10.  Asthma medications: basic pharmacology and use in the athlete.

Authors:  J E Houglum
Journal:  J Athl Train       Date:  2000-04       Impact factor: 2.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.